Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

PTI

Proteostasis Therapeutics (PTI)

Proteostasis Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PTI
일자시간출처헤드라인심볼기업
2023/06/2920:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/2820:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/1705:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/1705:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/1705:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/1323:32Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/1306:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/0922:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/0205:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PTIProteostasis Therapeutics Inc
2023/05/2422:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/05/2322:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/05/1206:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIProteostasis Therapeutics Inc
2023/05/1206:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/05/0305:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/2906:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/2906:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/2906:12Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/2206:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/2021:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1800:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1506:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1220:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
 검색 관련기사 보기:NASDAQ:PTI